Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic corticosteroids versus interferon alfa-2a versus observation for Birdshot retinochoroidopathy with macular edema
2006-003002-26Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of interferon alfa, methylprednisolone sodium succinate and prednisone in birdshot chorioretinitis (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Reduction in macular thickness at 4 months. Started Dec 2006; status: active.
02
Drugs
interferon alfamethylprednisolone sodium succinateprednisone
03
Conditions
birdshot chorioretinitis
Beyond the preview
Go deeper on 2006-003002-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003002-26.